STERIALS

A biotechnology company focused on developing non-addictive pain management product candidates using a proprietary drug delivery platform that optimizes and targets drug delivery. The company is developing an injectable liposomal bupivacaine formulation for post-surgical pain management, as well as treatments for post-traumatic stress disorder and rare pediatric epilepsy. Based in Delaware.